Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness.
Owusu, R; Mvundura, M; Nonvignon, J; Armah, G; Bawa, J; Antwi-Agyei, KO; Amponsa-Achiano, K; Dadzie, F; Bonsu, G; CLARK, A; Pecenka, C; Debellut, F;
2023
PLOS global public health, (2023).3 8 10.1371/journal.pgph.0001328.
Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines.
WATERLOW, NR; PROCTER, SR; EGGO, RM; JIT, M;
2023
BMC medicine, (2023).21 1 10.1186/s12916-023-02996-3.
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
AUZENBERGS, M; FU, H; ABBAS, K; PROCTER, SR; Cutts, FT; JIT, M;
2023
The Lancet. Global health, (2023).11 8 10.1016/S2214-109X(23)00220-6.
Time to change the way we think about tuberculosis infection prevention and control in health facilities: insights from recent research.
Yates, TA; Karat, AS; BOZZANI, F; MCCREESH, N; MacGregor, H; Beckwith, PG; GOVENDER, I; Colvin, CJ; Kielmann, K; GRANT, AD;
2023
Antimicrobial stewardship & healthcare epidemiology : ASHE, (2023).3 1 10.1017/ash.2023.192.
Using Age-Specific Values for Pediatric HRQoL in Cost-Effectiveness Analysis: Is There a Problem to Be Solved? If So, How?.
Devlin, NJ; Pan, T; Sculpher, M; JIT, M; Stolk, E; Rowen, D; Van Hout, B; Norman, R;
2023
PharmacoEconomics, (2023).41 10 10.1007/s40273-023-01300-8.
Designing economic evaluations for transferability: A critical review and practical guide.
PITT, C; HANSON, K; Goodman, C;
2023
(2023).
Evaluation framework study assessing the role, applicability and adherence to good practice of planning support tools for allocation of development aid for health in low-income and middle-income countries.
Megiddo, I; Blair, S; Sabei, D; RUIZ, F; Morton, AD;
2023
BMJ Open, (2023).13 7 10.1136/bmjopen-2022-069590.
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries.
Portnoy, A; CLARK, RA; Weerasuriya, CK; Mukandavire, C; Quaife, M; Bakker, R; Garcia Baena, I; Gebreselassie, N; Zignol, M; JIT, M; WHITE, RG; Menzies, NA;
2023
BMJ global health, (2023).8 7 10.1136/bmjgh-2023-012466.
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
Portnoy, A; Arcand, J-L; CLARK, RA; Weerasuriya, CK; Mukandavire, C; Bakker, R; Patouillard, E; Gebreselassie, N; Zignol, M; JIT, M; WHITE, RG; Menzies, NA;
2023
PLoS medicine, (2023).20 7 10.1371/journal.pmed.1004252.
Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries.
Levin, A; Burgess, C; Shendale, S; Morgan, W; Cw Hutubessy, R; Measles–rubella Eradication Modelling Group,; JIT, M; Measles-rubella Eradication Modelling Group,;
2023
BMJ global health, (2023).8 7 10.1136/bmjgh-2022-011526.